Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott T Tagawa

Showing results (51-60 of 208) with videos related to

Pageof 21
Sort By:
European Urology Focus|June 11, 2026
How Will PSMAddition Impact the Management of Prostate Cancer?Valentina Marulanda-Corzo, Aaron N Holmes, Vinay K Giri, et al.
Urologic Oncology|October 10, 2017
Metastasectomy in older adults with urothelial carcinoma: Population-based analysis of use and outcomesBishoy M Faltas, Renee L Gennarelli, Elena Elkin, et al.
BJUI Compass|April 27, 2022
Subcutaneous in situ gel delivered leuprolide acetate's consistent and prolonged drug delivery maintains effective testosterone suppression independent of age and weight in men with prostate cancerJoseph F Renzulli, Scott T Tagawa, Stuart N Atkinson, et al.
Current Treatment Options in Oncology|March 26, 2025
Advances in PSMA-Targeted Radionuclide TherapeuticsSamuel Ruder, Andres Ricaurte-Fajardo, Michael Sun, et al.
Neurology. Clinical Practice|May 11, 2026
Temporal Trends in the Frequency of Concomitant Cancer and Cerebrovascular Disease Diagnoses in the United StatesMorin Beyeler, Lillie Lanphier, Cenai Zhang, et al.
Frontiers in Oncology|October 23, 2012
Isolation and characterization of circulating tumor cells in prostate cancerElan Diamond, Guang Yu Lee, Naveed H Akhtar, et al.
Cancer|May 30, 2026
Top advances of the year: Radiopharmaceutical therapy for prostate cancerValentina Marulanda-Corzo, Sophia Coraci, Preeti Kakkar, et al.
The Prostate|March 24, 2023
Response to RL-225Ac in prostate cancer: Effect of prior treatment with RL-177Lu: A systematic review of the literatureJudith Stangl-Kremser, Andres Ricaurte-Fajardo, Kritika Subramanian, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|January 15, 2022
Adherence to Guideline-Recommended Cancer Screening in Stroke Survivors: A Nationwide AnalysisMarialaura Simonetto, Stephanie Rutrick, Natalie M LeMoss, et al.
Cancer Medicine|November 2, 2021
Treatment patterns and survival in metastatic castration-sensitive prostate cancer in the US Veterans Health AdministrationStephen J Freedland, Rickard Sandin, Janvi Sah, et al.
Pageof 21

Showing results (51-60 of 208) with videos related to

Sort By:
Pageof 21
European Urology Focus|June 11, 2026
How Will PSMAddition Impact the Management of Prostate Cancer?Valentina Marulanda-Corzo, Aaron N Holmes, Vinay K Giri, et al.
Urologic Oncology|October 10, 2017
Metastasectomy in older adults with urothelial carcinoma: Population-based analysis of use and outcomesBishoy M Faltas, Renee L Gennarelli, Elena Elkin, et al.
BJUI Compass|April 27, 2022
Subcutaneous in situ gel delivered leuprolide acetate's consistent and prolonged drug delivery maintains effective testosterone suppression independent of age and weight in men with prostate cancerJoseph F Renzulli, Scott T Tagawa, Stuart N Atkinson, et al.
Current Treatment Options in Oncology|March 26, 2025
Advances in PSMA-Targeted Radionuclide TherapeuticsSamuel Ruder, Andres Ricaurte-Fajardo, Michael Sun, et al.
Neurology. Clinical Practice|May 11, 2026
Temporal Trends in the Frequency of Concomitant Cancer and Cerebrovascular Disease Diagnoses in the United StatesMorin Beyeler, Lillie Lanphier, Cenai Zhang, et al.
Frontiers in Oncology|October 23, 2012
Isolation and characterization of circulating tumor cells in prostate cancerElan Diamond, Guang Yu Lee, Naveed H Akhtar, et al.
Cancer|May 30, 2026
Top advances of the year: Radiopharmaceutical therapy for prostate cancerValentina Marulanda-Corzo, Sophia Coraci, Preeti Kakkar, et al.
The Prostate|March 24, 2023
Response to RL-225Ac in prostate cancer: Effect of prior treatment with RL-177Lu: A systematic review of the literatureJudith Stangl-Kremser, Andres Ricaurte-Fajardo, Kritika Subramanian, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|January 15, 2022
Adherence to Guideline-Recommended Cancer Screening in Stroke Survivors: A Nationwide AnalysisMarialaura Simonetto, Stephanie Rutrick, Natalie M LeMoss, et al.
Cancer Medicine|November 2, 2021
Treatment patterns and survival in metastatic castration-sensitive prostate cancer in the US Veterans Health AdministrationStephen J Freedland, Rickard Sandin, Janvi Sah, et al.
Pageof 21